skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies

Piha‐Paul, Sarina A. ; Oh, Do‐Youn ; Ueno, Makoto ; Malka, David ; Chung, Hyun Cheol ; Nagrial, Adnan ; Kelley, Robin K. ; Ros, Willeke ; Italiano, Antoine ; Nakagawa, Kazuhiko ; Rugo, Hope S. ; Braud, Filippo ; Varga, Andrea Iolanda ; Hansen, Aaron ; Wang, Hui ; Krishnan, Suba ; Norwood, Kevin G. ; Doi, Toshihiko

International journal of cancer, 2020-10, Vol.147 (8), p.2190-2198 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
2
Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study
Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study

Mehnert, Janice M. ; Bergsland, Emily ; O’Neil, Bert H. ; Santoro, Armando ; Schellens, Jan H. M. ; Cohen, Roger B. ; Doi, Toshihiko ; Ott, Patrick A. ; Pishvaian, Michael J. ; Puzanov, Igor ; Aung, Kyaw L. ; Hsu, Chiun ; Le Tourneau, Christophe ; Hollebecque, Antoine ; Élez, Elena ; Tamura, Kenji ; Gould, Marlena ; Yang, Ping ; Stein, Karen ; Piha‐Paul, Sarina A.

Cancer, 2020-07, Vol.126 (13), p.3021-3030 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study

Ravi, Vinod ; Subramaniam, Aparna ; Zheng, Jing ; Amini, Behrang ; Trinh, Van A. ; Joseph, Jocelyn ; Mennel, Robert G. ; Bishop, Andrew J. ; Sturgis, Erich M. ; Goepfert, Ryan P. ; Yalamanchili, Sudha ; Botello, Gilberto ; Stephen, Bettzy ; Piha‐Paul, Sarina A. ; Patel, Anisha B. ; Lazar, Alexander J. ; Conley, Anthony P. ; Benjamin, Robert S. ; Patel, Shreyaskumar R. ; Futreal, Phillip A. ; Somaiah, Neeta ; Naing, Aung

Cancer, 2022-09, Vol.128 (18), p.3383-3391 [Periódico revisado por pares]

Atlanta: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

Cousin, Sophie ; Blay, Jean‐Yves ; Garcia, Irene Braña ; Bono, Johann S. ; Le Tourneau, Christophe ; Moreno, Victor ; Trigo, Jose ; Hann, Christine L. ; Azad, Arun A. ; Im, Seock‐Ah ; Cassier, Philippe A. ; French, Christopher A. ; Italiano, Antoine ; Keedy, Vicki L. ; Plummer, Ruth ; Sablin, Marie‐Paule ; Hemming, Matthew L. ; Ferron‐Brady, Geraldine ; Wyce, Anastasia ; Khaled, Ahmed ; Datta, Antara ; Foley, Shawn W. ; McCabe, Michael T. ; Wu, Yuehui ; Horner, Thierry ; Kremer, Brandon E. ; Dhar, Arindam ; O'Dwyer, Peter J. ; Shapiro, Geoffrey I. ; Piha‐Paul, Sarina A.

International journal of cancer, 2022-03, Vol.150 (6), p.993-1006 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
5
Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors

Janku, Filip ; Hong, David S. ; Fu, Siqing ; Piha-Paul, Sarina A. ; Naing, Aung ; Falchook, Gerald S. ; Tsimberidou, Apostolia M. ; Stepanek, Vanda M. ; Moulder, Stacy L. ; Lee, J. Jack ; Luthra, Rajyalakshmi ; Zinner, Ralph G. ; Broaddus, Russell R. ; Wheler, Jennifer J. ; Kurzrock, Razelle

Cell reports (Cambridge), 2014-01, Vol.6 (2), p.377-387 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies
Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Knisely, Anne ; Ahmed, Jibran ; Stephen, Bettzy ; Piha‐Paul, Sarina A. ; Karp, Daniel ; Zarifa, Abdulrazzak ; Fu, Siqing ; Hong, David Sanghyun ; Rodon Ahnert, Jordi ; Yap, Timothy A. ; Tsimberidou, Apostolia M. ; Alshawa, Anas ; Dumbrava, Ecaterina E. ; Yang, Yali ; Song, Juhee ; Meric‐Bernstam, Funda ; Jazaeri, Amir A. ; Naing, Aung

Cancer, 2024-02, Vol.130 (3), p.400-409 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
7
Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development
Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development
Material Type:
Artigo 		Adicionar ao Meu Espaço

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Steeghs, Neeltje ; Hansen, Aaron R. ; Hanna, Glenn J. ; Garralda, Elena ; Park, Haeseong ; Strauss, James ; Adam, Michael ; Campbell, Gossett ; Carver, Jennifer ; Easton, Rachael ; Mays, Katherine ; Skrdla, Peter ; Struemper, Herbert ; Washburn, Michael L. ; Matheny, Christopher ; Piha‐Paul, Sarina A.

Clinical and translational science, 2022-11, Vol.15 (11), p.2625-2639 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
8
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Chung, Hyun Cheol ; Ros, Willeke ; Delord, Jean-Pierre ; Perets, Ruth ; Italiano, Antoine ; Shapira-Frommer, Ronnie ; Manzuk, Lyudmila ; Piha-Paul, Sarina A ; Xu, Lei ; Zeigenfuss, Susan ; Pruitt, Scott K ; Leary, Alexandra

Journal of clinical oncology, 2019-06, Vol.37 (17), p.1470-1478 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers
Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers

Janku, Filip ; Sakamuri, Divya ; Kato, Shumei ; Huang, Helen J. ; Call, S. Greg ; Naing, Aung ; Holley, Veronica R. ; Patel, Sapna P. ; Amaria, Rodabe N. ; Falchook, Gerald S. ; Piha‐Paul, Sarina A. ; Zinner, Ralph G. ; Tsimberidou, Apostolia M. ; Hong, David S. ; Meric‐Bernstam, Funda

Cancer, 2021-02, Vol.127 (3), p.391-402 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Meric-Bernstam, Funda ; Johnson, Amber M ; Dumbrava, Ecaterina E Ileana ; Raghav, Kanwal ; Balaji, Kavitha ; Bhatt, Michelle ; Murthy, Rashmi K ; Rodon, Jordi ; Piha-Paul, Sarina A

Clinical cancer research, 2019-04, Vol.25 (7), p.2033-2041 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (489)
  2. Revistas revisadas por pares (484)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (548)
  2. Outros  (2)
  3. Reports  (2)
  4. Imagens  (1)
  5. Anais de Congresso  (1)
  6. Videos  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2011  (3)
  2. 2011Até2013  (63)
  3. 2014Até2016  (154)
  4. 2017Até2020  (178)
  5. Após 2020  (157)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.